Osphos (clodronate)
Equine Lameness (Navicular Syndrome/Bone Spavin)
ApprovedCommercial
Key Facts
Indication
Equine Lameness (Navicular Syndrome/Bone Spavin)
Phase
Approved
Status
Commercial
Company
About Virbac SA
Virbac is a leading independent animal health company with a mission to improve the health and well-being of animals through innovative pharmaceutical solutions. Founded in 1968, it has grown into a global organization with a direct commercial presence in major markets and a diverse portfolio spanning pharmaceuticals, biologicals, and nutritional supplements. The company's strategy focuses on internal R&D, strategic acquisitions, and geographic expansion, particularly in emerging markets, to drive sustainable growth in the dynamic veterinary health sector.
View full company profile